Source: International Congress 2019 – Novel targets and mechanisms in asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
W. Chen (Oxford, United Kingdom), R. Borst (Oxford, United Kingdom), J. Luo (Oxford, United Kingdom), M. Chizari (Oxford, United Kingdom), L. Chocarro De Erauso (Oxford, United Kingdom), V. Erpenbeck (Basel, Switzerland), S. Kazani (Cambridge MA, United States of America), D. Sandham (Cambridge MA, United States of America), L. Xue (Oxford, United Kingdom). Fevipiprant antagonises prostaglandin D2-induced activation of type-2 CD8 T cells (Tc2). 4953

Member's Comments

No comment yet.

Related content which might interest you: Effects of CD4+CD25+ T cells on the production of IL-4, IL-5 and IFN-γ by CD4+ T cells in asthmatic mice Source: Eur Respir J 2005; 26: Suppl. 49, 24s Year: 2005 NFAT subtypes in regulating Th2 lymphocytes Source: Annual Congress 2012 - COPD treatments: efficacy and safety Year: 2012 Selective NF-κB inhibition of activated/memory (CD45RO+) T cells by novel mutated IκBα in asthma Source: Eur Respir J 2007; 30: Suppl. 51, 497s Year: 2007 The up-regulation of cysteinyl-leukotriene receptors on T cells Source: Eur Respir J 2003; 22: Suppl. 45, 395s Year: 2003 Increased pro-inflammatory regulatory T Cells correlate with the plasticity of T helper cell differentiation in asthma Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases Year: 2018 CD4+ and CD8+ T lymphocytes display a Th2/Tc2 cytokine profile in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 319s Year: 2004 NKG2D triggers MHC I unrestricted effector function of alloreactive CD8+ T cells Source: Annual Congress 2008 - Best of lung epithelial cells 2008 Year: 2008 Diminished levels of IL-7 receptor-positive CD4+ T cells in asthmatic patients are up-regulated by glucocorticoid therapy. No effects on IL-7R-negative regulatory CD4+ T cells Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation Year: 2010 Macrophages induce an allergen-specific and long-term suppression in a mouse asthma model Source: Eur Respir J 2005; 26: 1040-1046 Year: 2005 Effects of dendritic cells overexpressing Serrate1 on the polarization of CD4+CD25+ T cells and the production of inhibitory cytokines in vitro Source: Eur Respir J 2005; 26: Suppl. 49, 25s Year: 2005 High concentration of antigen induces allergic mice T cells anergy with depressing CD86 expression on antigen-presenting cells Source: Eur Respir J 2002; 20: Suppl. 38, 28s Year: 2002 Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s) Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 Control of bystander T-cells responses by CD4+CD25+ cytolytic regulatory T-cells Source: Eur Respir J 2005; 26: Suppl. 49, 24s Year: 2005 Decreased perforin and granzyme B expression in peripheral blood CD8+ T cells in emphysema Source: Eur Respir J 2005; 26: Suppl. 49, 105s Year: 2005 Enhanced expression of IL-18 and increased CD8+ T cells and eosinophils in the airways of asthma death Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation Year: 2010 Inflammatory process of CD8+ CD28- T cells in induced sputum from asthmatic patients Source: Eur Respir J 2005; 26: Suppl. 49, 25s Year: 2005 Modified mRNA encoding Foxp3 protects against allergic asthma in mice by rebalancing T helper cell responses through an IL-23 / IL-17A-dependent mechanism Source: Annual Congress 2012 - Treating childhood asthma Year: 2012 IL-15 transpresentation in circulating progenitors of NK cells controls their differentiation potential, STAT6 activation and IL-13 production Source: Annual Congress 2005 - Regulation of the allergic and asthmatic response Year: 2005 IL-10 produced by CD4+ T cells is essential for the development of airway hyperresponsiveness via suppression of endogenous IL-12 Source: Eur Respir J 2005; 26: Suppl. 49, 24s Year: 2005 IL-15 promotes the growth of both CD4 and CD8 T cells derived from endobronchial tissue Source: Eur Respir J 2006; 28: Suppl. 50, 745s Year: 2006